He Liang Fu
Chairman at JIANGSU AIDEA PHARMACEUTICAL CO., LTD.
Net worth: 3 M $ as of 2024-03-30
Profile
He Liang Fu is currently the Chairman at Jiangsu Aidea Pharmaceutical Co., Ltd.
He previously held the position of President at Techpool Bio-Pharma Co., Ltd.
and was a Professor at Sun Yat-Sen University.
He obtained his undergraduate degree from Nanjing University in 1989.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-08-29 | 721,283 ( 0.33% ) | 2 M $ | 2024-03-30 | |
2022-12-28 | 1,167,600 ( 0.23% ) | 2 M $ | 2024-03-30 |
He Liang Fu active positions
Companies | Position | Start |
---|---|---|
JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Chairman | 2013-12-31 |
Former positions of He Liang Fu
Companies | Position | End |
---|---|---|
Sun Yat-Sen University | Corporate Officer/Principal | - |
Techpool Bio-Pharma Co., Ltd.
Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | President | - |
Training of He Liang Fu
Nanjing University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Techpool Bio-Pharma Co., Ltd.
Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | Health Technology |
- Stock Market
- Insiders
- He Liang Fu